Procter & GamblePGCOMMENTFeb 14, 2014Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
The premier consumer product company. Good quality product. Exposed to the global market. Has been somewhat slow growing for the last few years. Organically their basically looking at low single digit growth. With cost-cutting and stock buyback, they may be able to get a 5%-8% upside per year, which he doesn’t think is enough for most portfolios. Longer-term, he doesn’t see anything wrong with it.